nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP1A2—Carmustine—lymphatic system cancer	0.33	0.35	CbGbCtD
Ramelteon—CYP2C19—Teniposide—lymphatic system cancer	0.24	0.255	CbGbCtD
Ramelteon—CYP3A4—Cytarabine—lymphatic system cancer	0.118	0.125	CbGbCtD
Ramelteon—CYP3A4—Teniposide—lymphatic system cancer	0.116	0.123	CbGbCtD
Ramelteon—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0812	0.0863	CbGbCtD
Ramelteon—CYP3A4—Vincristine—lymphatic system cancer	0.0559	0.0594	CbGbCtD
Ramelteon—Depression—Mechlorethamine—lymphatic system cancer	0.00295	0.0494	CcSEcCtD
Ramelteon—Thinking abnormal—Carmustine—lymphatic system cancer	0.00239	0.0401	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.002	0.0335	CcSEcCtD
Ramelteon—Mental disability—Carmustine—lymphatic system cancer	0.0019	0.0319	CcSEcCtD
Ramelteon—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00188	0.0316	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00153	0.0256	CcSEcCtD
Ramelteon—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00129	0.0216	CcSEcCtD
Ramelteon—Arthralgia—Fludarabine—lymphatic system cancer	0.00127	0.0214	CcSEcCtD
Ramelteon—Myalgia—Fludarabine—lymphatic system cancer	0.00127	0.0214	CcSEcCtD
Ramelteon—Depression—Carmustine—lymphatic system cancer	0.00122	0.0205	CcSEcCtD
Ramelteon—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00122	0.0205	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00119	0.0199	CcSEcCtD
Ramelteon—Depression—Vincristine—lymphatic system cancer	0.00117	0.0196	CcSEcCtD
Ramelteon—Nausea—Mechlorethamine—lymphatic system cancer	0.00112	0.0188	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00111	0.0187	CcSEcCtD
Ramelteon—Fatigue—Fludarabine—lymphatic system cancer	0.00105	0.0177	CcSEcCtD
Ramelteon—Asthenia—Teniposide—lymphatic system cancer	0.000997	0.0167	CcSEcCtD
Ramelteon—Diarrhoea—Teniposide—lymphatic system cancer	0.000951	0.0159	CcSEcCtD
Ramelteon—Myalgia—Bleomycin—lymphatic system cancer	0.000934	0.0157	CcSEcCtD
Ramelteon—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000895	0.015	CcSEcCtD
Ramelteon—Asthenia—Fludarabine—lymphatic system cancer	0.000876	0.0147	CcSEcCtD
Ramelteon—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000872	0.0146	CcSEcCtD
Ramelteon—Headache—Teniposide—lymphatic system cancer	0.00087	0.0146	CcSEcCtD
Ramelteon—Diarrhoea—Fludarabine—lymphatic system cancer	0.000835	0.014	CcSEcCtD
Ramelteon—Nausea—Teniposide—lymphatic system cancer	0.000825	0.0138	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000816	0.0137	CcSEcCtD
Ramelteon—Myalgia—Carmustine—lymphatic system cancer	0.000815	0.0137	CcSEcCtD
Ramelteon—Myalgia—Vincristine—lymphatic system cancer	0.000778	0.0131	CcSEcCtD
Ramelteon—Headache—Fludarabine—lymphatic system cancer	0.000765	0.0128	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000761	0.0128	CcSEcCtD
Ramelteon—Myalgia—Mitoxantrone—lymphatic system cancer	0.000758	0.0127	CcSEcCtD
Ramelteon—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000758	0.0127	CcSEcCtD
Ramelteon—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000746	0.0125	CcSEcCtD
Ramelteon—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000727	0.0122	CcSEcCtD
Ramelteon—Nausea—Fludarabine—lymphatic system cancer	0.000725	0.0122	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000712	0.0119	CcSEcCtD
Ramelteon—Insomnia—Carmustine—lymphatic system cancer	0.000707	0.0119	CcSEcCtD
Ramelteon—Somnolence—Carmustine—lymphatic system cancer	0.000695	0.0117	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00068	0.0114	CcSEcCtD
Ramelteon—Insomnia—Vincristine—lymphatic system cancer	0.000675	0.0113	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000662	0.0111	CcSEcCtD
Ramelteon—Somnolence—Mitoxantrone—lymphatic system cancer	0.000646	0.0108	CcSEcCtD
Ramelteon—Fatigue—Vincristine—lymphatic system cancer	0.000643	0.0108	CcSEcCtD
Ramelteon—Asthenia—Bleomycin—lymphatic system cancer	0.000642	0.0108	CcSEcCtD
Ramelteon—Fatigue—Mitoxantrone—lymphatic system cancer	0.000626	0.0105	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000592	0.00993	CcSEcCtD
Ramelteon—Depression—Methotrexate—lymphatic system cancer	0.000566	0.0095	CcSEcCtD
Ramelteon—Asthenia—Carmustine—lymphatic system cancer	0.000561	0.00941	CcSEcCtD
Ramelteon—Asthenia—Vincristine—lymphatic system cancer	0.000535	0.00898	CcSEcCtD
Ramelteon—Diarrhoea—Carmustine—lymphatic system cancer	0.000535	0.00897	CcSEcCtD
Ramelteon—Nausea—Bleomycin—lymphatic system cancer	0.000532	0.00892	CcSEcCtD
Ramelteon—Asthenia—Mitoxantrone—lymphatic system cancer	0.000521	0.00875	CcSEcCtD
Ramelteon—Dizziness—Carmustine—lymphatic system cancer	0.000517	0.00867	CcSEcCtD
Ramelteon—Diarrhoea—Vincristine—lymphatic system cancer	0.00051	0.00856	CcSEcCtD
Ramelteon—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000497	0.00834	CcSEcCtD
Ramelteon—Dizziness—Vincristine—lymphatic system cancer	0.000493	0.00828	CcSEcCtD
Ramelteon—Headache—Carmustine—lymphatic system cancer	0.00049	0.00821	CcSEcCtD
Ramelteon—Headache—Vincristine—lymphatic system cancer	0.000467	0.00784	CcSEcCtD
Ramelteon—Nausea—Carmustine—lymphatic system cancer	0.000464	0.00779	CcSEcCtD
Ramelteon—Headache—Mitoxantrone—lymphatic system cancer	0.000455	0.00764	CcSEcCtD
Ramelteon—Nausea—Vincristine—lymphatic system cancer	0.000443	0.00743	CcSEcCtD
Ramelteon—Dysgeusia—Methotrexate—lymphatic system cancer	0.000434	0.00729	CcSEcCtD
Ramelteon—Nausea—Mitoxantrone—lymphatic system cancer	0.000432	0.00724	CcSEcCtD
Ramelteon—Arthralgia—Methotrexate—lymphatic system cancer	0.000378	0.00634	CcSEcCtD
Ramelteon—Myalgia—Methotrexate—lymphatic system cancer	0.000378	0.00634	CcSEcCtD
Ramelteon—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000362	0.00607	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00033	0.00553	CcSEcCtD
Ramelteon—Insomnia—Methotrexate—lymphatic system cancer	0.000327	0.00549	CcSEcCtD
Ramelteon—Somnolence—Methotrexate—lymphatic system cancer	0.000322	0.0054	CcSEcCtD
Ramelteon—Fatigue—Methotrexate—lymphatic system cancer	0.000312	0.00524	CcSEcCtD
Ramelteon—Asthenia—Methotrexate—lymphatic system cancer	0.00026	0.00436	CcSEcCtD
Ramelteon—Diarrhoea—Methotrexate—lymphatic system cancer	0.000248	0.00416	CcSEcCtD
Ramelteon—Dizziness—Methotrexate—lymphatic system cancer	0.000239	0.00402	CcSEcCtD
Ramelteon—Headache—Methotrexate—lymphatic system cancer	0.000227	0.0038	CcSEcCtD
Ramelteon—Nausea—Methotrexate—lymphatic system cancer	0.000215	0.00361	CcSEcCtD
